Stay updated on Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial
Sign up to get notified when there's something new on the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page.

Latest updates to the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.3.4 was added; Melanoma and related topics, including MedlinePlus Genetics and Revision: v3.3.3, were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedDifference0.2%

- Check42 days agoChange DetectedAdded Melanoma to related topics and included a MedlinePlus Genetics link on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check49 days agoChange DetectedDifference0.2%

- Check56 days agoChange DetectedRevision metadata updated from v3.2.0 to v3.3.2 on the page.SummaryDifference0.1%

- Check63 days agoChange DetectedNew related-topic links for Melanoma and MedlinePlus Genetics appear on the page, and a government funding-status notice for NIH operations has been removed.SummaryDifference0.6%

Stay in the know with updates to Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page.